Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Update

Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) saw a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 32,908,100 shares, an increase of 236,648.9% from the June 15th total of 13,900 shares. Based on an average trading volume of 800 shares, the days-to-cover ratio is presently 41,135.1 days.

Sino Biopharmaceutical Stock Performance

Shares of OTCMKTS SBMFF opened at $0.32 on Friday. Sino Biopharmaceutical has a 52 week low of $0.31 and a 52 week high of $0.49. The business’s 50 day moving average price is $0.33 and its 200 day moving average price is $0.36.

About Sino Biopharmaceutical

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, pomalidomide capsules under Anyue brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, and trastuzumab for injection under Saituo brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand and colistimethate sodium for injection under Tianyun brand.